Puliyanda, Dechu P <br/><br/>
Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation.  [electronic resource] 

 -  Pediatric transplantation  05 2020 
 - e13685 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1399-3046 
<br/><br/><label>Standard No.: </label>10.1111/petr.13685  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Alemtuzumab--therapeutic use<br/>Antilymphocyte Serum--therapeutic use<br/>Child<br/>Child, Preschool<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Induction Chemotherapy--methods<br/>Infant<br/>Infant, Newborn<br/>Kidney Transplantation<br/>Male<br/>Steroids<br/>Treatment Outcome